Understanding the effects of banning menthol in cigarettes and e-cigarettes on smokers
Evaluating the potential impact of a menthol ban in cigarettes and e-cigarettes among current menthol smokers
This study is looking at how banning menthol flavors in cigarettes and e-cigarettes might change the smoking habits of people who currently smoke menthol, especially in the Black community, and it will involve 150 adult menthol smokers to help understand these effects better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11057676 on NIH RePORTER |
What this research studies
This research investigates the potential impact of banning menthol flavor in cigarettes and e-cigarettes on current menthol smokers. It aims to understand how such a ban could influence smoking behavior and nicotine dependence among adults, particularly focusing on the Black community, which has higher rates of menthol cigarette use. The study will recruit 150 adult participants who currently smoke menthol cigarettes and will assign them to different scenarios to model the effects of menthol regulations. By analyzing these behaviors, the research seeks to provide insights into public health strategies for reducing smoking rates.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who currently smoke menthol cigarettes.
Not a fit: Patients who do not smoke menthol cigarettes or are under 21 years old may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective tobacco regulations that help reduce smoking rates and improve public health outcomes.
How similar studies have performed: Previous research has indicated that flavor bans in tobacco products can lead to decreased smoking rates, suggesting that this approach may be effective.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Bold, Krysten W. — Yale University
- Study coordinator: Bold, Krysten W.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.